Neurologix (Neurologix) ROE % Adjusted to Book Value : 0.00% (As of Jun. 2011)

View and export this data going back to . Start your Free Trial

What is Neurologix ROE % Adjusted to Book Value?

Neurologix's ROE % for the quarter that ended in Jun. 2011 was 0.00%. Neurologix's PB Ratio for the quarter that ended in Jun. 2011 was N/A. Neurologix's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2011 was N/A.

Neurologix ROE % Adjusted to Book Value Historical Data

The historical data trend for Neurologix's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix ROE % Adjusted to Book Value Chart

Neurologix Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-53.30

-29.11

-89.03

-29.52

Neurologix Quarterly Data
	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-	-	Negative Equity	-	-

Competitive Comparison of Neurologix's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Neurologix's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurologix's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurologix's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Neurologix's ROE % Adjusted to Book Value falls into.

Neurologix ROE % Adjusted to Book Value Calculation

Neurologix's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2010 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-1,671.55%	/	N/A
	=	N/A

Neurologix's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2011 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.00%	/	N/A
	=	N/A

Neurologix ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Neurologix's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurologix (Neurologix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Bridge Plaza, Fort Lee, NJ, USA, 07024

Website

http://www.neurologix.net

Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines